ProfileGDS4132 / 227475_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 59% 58% 71% 64% 60% 59% 62% 66% 67% 59% 61% 63% 66% 71% 65% 61% 61% 68% 66% 60% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101164.37459
GSM201543Muscle PCOS pioglitazone 121153.7358
GSM201544Muscle PCOS pioglitazone 161221.8171
GSM201545Muscle PCOS pioglitazone 201195.74964
GSM201829Muscle PCOS pioglitazone 231176.87960
GSM201830Muscle PCOS pioglitazon 251168.76359
GSM201831Muscle PCOS pioglitazone 271180.12662
GSM201832Muscle PCOS pioglitazone 31185.27566
GSM201833Muscle PCOS pioglitazone 41182.97267
GSM201834Muscle PCOS pioglitazone 81160.79359
GSM201835Muscle PCOS after pioglitazone 102159.95861
GSM201836Muscle PCOS after pioglitazone 122171.34863
GSM201837Muscle PCOS after pioglitazone 162171.13166
GSM201838Muscle PCOS after pioglitazone 202214.93371
GSM201839Muscle PCOS after pioglitazone 232186.39465
GSM201840Muscle PCOS after pioglitazone 252168.77261
GSM201841Muscle PCOS after pioglitazone 272154.96261
GSM201842Muscle PCOS after pioglitazone 32176.61868
GSM201843Muscle PCOS after pioglitazone 42185.05166
GSM201844Muscle PCOS after pioglitazone 82165.35660